163 related articles for article (PubMed ID: 2117172)
1. Mucolytics: when dispensable, when necessary?
Dorow P
Lung; 1990; 168 Suppl():622-6. PubMed ID: 2117172
[TBL] [Abstract][Full Text] [Related]
2. Aerosol Medications for Treatment of Mucus Clearance Disorders.
Rubin BK
Respir Care; 2015 Jun; 60(6):825-9; discussion 830-32. PubMed ID: 26070577
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of nebulised acetylcysteine and normal saline in the treatment of sputum retention following thoracotomy.
Gallon AM
Thorax; 1996 Apr; 51(4):429-32. PubMed ID: 8733499
[TBL] [Abstract][Full Text] [Related]
4. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
[TBL] [Abstract][Full Text] [Related]
5. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
[TBL] [Abstract][Full Text] [Related]
6. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?
Bilton D; Stanford G
Curr Opin Pulm Med; 2014 Nov; 20(6):601-6. PubMed ID: 25221855
[TBL] [Abstract][Full Text] [Related]
7. An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases.
Ehre C; Rushton ZL; Wang B; Hothem LN; Morrison CB; Fontana NC; Markovetz MR; Delion MF; Kato T; Villalon D; Thelin WR; Esther CR; Hill DB; Grubb BR; Livraghi-Butrico A; Donaldson SH; Boucher RC
Am J Respir Crit Care Med; 2019 Jan; 199(2):171-180. PubMed ID: 30212240
[TBL] [Abstract][Full Text] [Related]
8. A comparison of a new mucolytic N-acetylcysteine L-lysinate with N-acetylcysteine: airway epithelial function and mucus changes in dog.
Tomkiewicz RP; App EM; De Sanctis GT; Coffiner M; Maes P; Rubin BK; King M
Pulm Pharmacol; 1995 Dec; 8(6):259-65. PubMed ID: 8819180
[TBL] [Abstract][Full Text] [Related]
9. [Bronchial mucus modifiers, antioxidants and antiproteases].
Polu JM; Chabot F; Wallaert B
Rev Mal Respir; 1993; 10(2):87-100. PubMed ID: 8502804
[No Abstract] [Full Text] [Related]
10. [Expectoration and inhalation therapy].
Nakamura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Nov; 28(11):1421-5. PubMed ID: 2290225
[TBL] [Abstract][Full Text] [Related]
11. [Expectoration disorders in patients with chronic obstructive lung diseases].
Solopov VN; Lunichkina IV
Klin Med (Mosk); 1990 May; 68(5):60-5. PubMed ID: 2398723
[TBL] [Abstract][Full Text] [Related]
12. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance].
Miyata T
Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863
[TBL] [Abstract][Full Text] [Related]
13. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Chong J; Cates CJ
Cochrane Database Syst Rev; 2015 Jul; (7):CD001287. PubMed ID: 26222376
[TBL] [Abstract][Full Text] [Related]
14. Erdosteine: Drug exhibiting polypharmacy for the treatment of respiratory diseases.
Dal Negro R; Pozzi E; Cella SG
Pulm Pharmacol Ther; 2018 Dec; 53():80-85. PubMed ID: 30352285
[TBL] [Abstract][Full Text] [Related]
15. A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases.
Addante A; Raymond W; Gitlin I; Charbit A; Orain X; Scheffler AW; Kuppe A; Duerr J; Daniltchenko M; Drescher M; Graeber SY; Healy AM; Oscarson S; Fahy JV; Mall MA
Eur Respir J; 2023 May; 61(5):. PubMed ID: 37080569
[TBL] [Abstract][Full Text] [Related]
16. The role of mucus in cough research.
Rubin BK
Lung; 2010 Jan; 188 Suppl 1():S69-72. PubMed ID: 19936981
[TBL] [Abstract][Full Text] [Related]
17. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
[TBL] [Abstract][Full Text] [Related]
18. Summary of the National Mucolytic Study.
Morgan EJ; Petty TL
Chest; 1990 Feb; 97(2 Suppl):24S-27S. PubMed ID: 2404710
[No Abstract] [Full Text] [Related]
19. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
Nash EF; Stephenson A; Ratjen F; Tullis E
Cochrane Database Syst Rev; 2009 Jan; (1):CD007168. PubMed ID: 19160327
[TBL] [Abstract][Full Text] [Related]
20. [Rheology of bronchial secretions and mucociliary transport (author's transl)].
Puchelle E; Girard F; Zahm JM
Bull Eur Physiopathol Respir; 1976; 12(6):771-9. PubMed ID: 1016804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
